There
is
little
doubt
that
final
victories
over
pandemics,
such
as
COVID-19,
are
attributed
to
herd
immunity,
either
through
post-disease
convalescence
or
active
immunization
of
a
high
percentage
the
world's
population
with
vaccines,
demonstrating
protection
from
infection
and
transmission,
being
available
in
large
quantities
at
reasonable
prices.
However,
it
assumable
humans
immune
defects
suppression,
e.g.,
consequence
allograft
transplantation,
cannot
be
immunized
actively
nor
produce
sufficient
responses
prevent
SARS-CoV-2
infections.
These
subjects
desperately
need
other
strategies,
sophisticated
measures
immunization.
Hypertonic
salt
solutions
attack
vulnerable
core
areas
viruses,
i.e.,
denatures
surface
proteins
thus
prohibits
virus
penetration
somatic
cells.
It
has
ensured
not
affected
by
denaturation
regarding
this
unspecific
protection.
Impregnating
filtering
facepieces
hypertonic
straightforward
way
inactivate
viruses
potential
pathogens.
As
result
contact
crystals
on
facepiece,
these
pathogens
become
denatured
inactivated
almost
quantitatively.
Such
strategy
could
easily
applied
fight
against
COVID-19
pandemic
ones
may
occur
future.
Another
possible
tool
passive
antibodies
SARS-CoV-2,
preferably
human
origin.
can
harvested
patients´
sera,
which
have
successfully
survived
their
infection.
The
disadvantage
rapid
decrease
immunoglobulin
titer
after
ends
overcome
immortalizing
antibody-producing
B-cells
via
fusion
with,
mouse
myeloma
resulting
monoclonal
then
origin
in,
least
theoretically,
unlimited
amounts.
Finally,
dry
blood
spots
valuable
for
surveilling
population´s
immunity.
Proceedings of the National Academy of Sciences,
Journal Year:
2023,
Volume and Issue:
120(23)
Published: May 30, 2023
The
antiviral
benefit
of
antibodies
can
be
compromised
by
viral
escape
especially
for
rapidly
evolving
viruses.
Therefore,
durable,
effective
must
both
broad
and
potent
to
counter
newly
emerging,
diverse
strains.
Discovery
such
is
critically
important
SARS-CoV-2
as
the
global
emergence
new
variants
concern
(VOC)
has
efficacy
therapeutic
vaccines.
We
describe
a
collection
neutralizing
monoclonal
(mAbs)
isolated
from
an
individual
who
experienced
breakthrough
infection
with
Delta
VOC.
Four
mAbs
potently
neutralize
Wuhan-Hu-1
vaccine
strain,
VOC,
also
retain
potency
against
Omicron
VOCs
through
BA.4/BA.5
in
pseudovirus-based
authentic
virus
assays.
Three
recently
circulating
XBB.1.5
BQ.1.1
one
neutralizes
SARS-CoV-1.
these
was
greater
than
all
but
that
had
been
approved
applications.
target
distinct
epitopes
on
spike
glycoprotein,
three
receptor-binding
domain
(RBD)
invariant
region
downstream
RBD
subdomain
1
(SD1).
pathways
we
defined
at
single
amino
acid
resolution
deep
mutational
scanning
show
they
conserved,
functionally
constrained
regions
suggesting
could
incur
fitness
cost.
Overall,
are
unique
their
breadth
across
VOCs,
epitope
specificity,
include
highly
mAb
targeting
rare
outside
SD1.
Antibodies,
Journal Year:
2025,
Volume and Issue:
14(1), P. 13 - 13
Published: Feb. 5, 2025
Serological
surveillance
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
antibodies
is
important
to
monitor
population
COVID-19
immunity.
Dried
blood
spots
(DBS)
are
a
valuable
method
for
serosurveys,
particularly
in
remote
settings
and
children.
We
compared
the
measurement
SARS-CoV-2
spike-specific
IgG
paired
samples
collected
using
standard
venepuncture
(serum)
hemaPEN®
microsampling
DBS
device
from
children
adults.
A
total
83
participants
(10
months
65
years
age),
comprising
COVID-positive
-negative
participants,
were
recruited.
Paired
serum
assayed
receptor-binding
domain
(RBD)
Spike
(S1)
an
established
in-house
ELISA.
RBD
S1
concentrations
hemaPEN
eluates
non-parametric
Wilcoxon
matched-pairs
signed
ranked
test.
Pearson's
correlation
was
used
level
agreement
between
assessed
by
Bland-Altman
analysis.
N
=
41
adults
(36
5
COVID-negative),
42
(37
COVID-positive,
COVID-negative)
have
assayed.
found
moderate
strong
correlations
(r
0.9472,
p
<
0.0001)
proteins
0.6892,
0.0001).
Similar
results
observed
both
adult
paediatric
populations.
No
significant
differences
S1-specific
levels
stored
up
35
weeks
at
room
temperature.
Eluted
showed
high
specificity
sensitivity
(100%
89.89%,
respectively)
with
serum.
The
use
sample
collection
feasible
approach
assessing
serosurveillance
studies,
Microbiology Spectrum,
Journal Year:
2022,
Volume and Issue:
10(3)
Published: May 25, 2022
Serological
surveillance
studies
of
infectious
diseases
provide
population-level
estimates
infection
and
antibody
prevalence,
generating
crucial
insight
into
immunity,
risk
factors
leading
to
infection,
effectiveness
public
health
measures.
These
traditionally
rely
on
detection
pathogen-specific
antibodies
in
samples
derived
from
venipuncture,
an
expensive
logistically
challenging
aspect
serological
surveillance.
During
the
COVID-19
pandemic,
guidelines
implemented
prevent
spread
SARS-CoV-2
made
collection
venous
blood
difficult
at
a
time
when
serosurveillance
was
urgently
needed.
Dried
spots
(DBS)
have
generated
interest
as
alternative
for
applications
due
their
stability,
low
cost,
ease
collection;
DBS
can
be
self-generated
via
fingerprick
by
community
members
mailed
ambient
temperatures.
Here,
we
detail
development
four
DBS-based
methods
demonstrate
implementation
large
survey
12
cities
East
Bay
region
San
Francisco
metropolitan
area
using
at-home
collection.
We
find
that
perform
similarly
plasma/serum
enzyme-linked
immunosorbent
assays
commercial
assays.
In
addition,
show
reliably
detect
responses
months
postinfection
track
kinetics
after
vaccination.
Implementation
enabled
valuable
data
our
study
population
investigate
changes
seroprevalence
over
8-month
period.
Our
work
makes
strong
argument
studies,
not
just
SARS-CoV-2,
but
any
situation
where
phlebotomy
is
inaccessible.
IMPORTANCE
Estimation
community-level
or
vaccination
critical
inform
responses.
Traditional
invasive
procedure
amenable
pandemic-related
social-distancing
are
since
they
self-collected
participants
home
do
require
refrigeration
shipment
storage.
However,
measure
levels
been
widely
utilized.
comparable
sampling
method
measured
distinct
The
format
longitudinal
cohort
samples,
ensuring
participants'
safety
during
ongoing
pandemic.
demonstrates
excellent
measuring
whenever
venipuncture
impractical.
Heliyon,
Journal Year:
2022,
Volume and Issue:
8(9), P. e10270 - e10270
Published: Aug. 28, 2022
The
extent
of
the
COVID-19
pandemic
will
be
better
understood
through
serosurveys
and
SARS-CoV-2
antibody
testing.
Dried
blood
spot
(DBS)
samples
play
a
central
role
in
large
scale
serosurveillance
by
simplifying
biological
specimen
collection
transportation,
especially
Canada.
Direct
comparative
performance
data
on
multiplex
assays
resulting
from
identical
DBS
are
currently
lacking.
In
our
study,
we
aimed
to
provide
for
BioPlex
2200
IgG
(Bio-Rad),
V-PLEX
Panel
2
(MSD),
Elecsys
Anti-SARS-CoV-2
(Roche)
commercial
assays,
as
well
two
highly
scalable
in-house
(University
Ottawa
Mount
Sinai
Hospital
protocols)
assess
their
suitability
DBS-based
serosurveillance.
These
were
evaluated
against
panels
collected
convalescent
patients
(
Scientific Reports,
Journal Year:
2023,
Volume and Issue:
13(1)
Published: Sept. 11, 2023
Abstract
The
ongoing
SARS-CoV-2
pandemic
was
initially
managed
by
non-pharmaceutical
interventions
such
as
diagnostic
testing,
isolation
of
positive
cases,
physical
distancing
and
lockdowns.
advent
vaccines
has
provided
crucial
protection
against
SARS-CoV-2.
Neutralising
antibody
(nAb)
responses
are
a
key
correlate
protection,
therefore
measuring
nAb
is
essential
for
monitoring
vaccine
efficacy.
Fingerstick
dried
blood
spots
(DBS)
ideal
use
in
large-scale
sero-surveillance
because
they
inexpensive,
offer
the
option
self-collection
can
be
transported
stored
at
ambient
temperatures.
Such
advantages
also
make
DBS
appealing
to
resource-limited
settings
potential
future
pandemics.
In
this
study,
sera,
venous
fingerstick
on
filter
paper
were
measured.
Samples
collected
from
acutely
infected
individuals,
convalescent
individuals
vaccinated
individuals.
Good
agreement
observed
between
measured
eluted
paired
sera.
Stability
sera
room
temperature
28
days.
Overall,
study
provides
support
viable
sample
collection
method
responses.
Scientific Reports,
Journal Year:
2023,
Volume and Issue:
13(1)
Published: Dec. 9, 2023
Serological
assays
measuring
antibodies
against
SARS-CoV-2
are
key
to
describe
the
epidemiology,
pathobiology
or
induction
of
immunity
after
infection
vaccination.
Of
those,
multiplex
targeting
multiple
antigens
especially
helpful
as
closely
related
coronaviruses
other
can
be
analysed
simultaneously
from
small
sample
volumes,
hereby
shedding
light
on
patterns
in
immune
response
that
would
otherwise
remain
undetected.
We
established
a
bead-based
17-plex
assay
detecting
all
pathogenic
for
humans:
SARS-CoV-2,
SARS-CoV,
MERS-CoV,
HCoV
strains
229E,
OC43,
HKU1,
and
NL63.
The
was
validated
five
commercial
serological
immunoassays,
surrogate
virus
neutralisation
test,
assay,
SARS-CoV-2.
It
found
highly
versatile
shown
by
antibody
detection
both
serum
dried
blot
spots
three
case
studies.
First,
we
followed
seroconversion
four
endemic
an
outbreak
study
day-care
centres
children.
Second,
were
able
link
more
severe
clinical
course
stronger
IgG
with
this
17-plex-assay,
which
IgG1
IgG3
dominated.
Finally,
our
discriminate
recent
previous
infections
calculating
IgG/IgM
ratio
N
antigen
antibodies.
In
conclusion,
due
comprehensive
method
comparison,
thorough
validation,
proven
versatility,
is
valuable
tool
studies
coronavirus
serology.
Critical Reviews in Clinical Laboratory Sciences,
Journal Year:
2023,
Volume and Issue:
61(1), P. 70 - 88
Published: Oct. 6, 2023
AbstractLaboratory
testing
has
been
a
key
tool
in
managing
the
SARS-CoV-2
global
pandemic.
While
rapid
antigen
and
PCR
proven
useful
for
diagnosing
acute
infections,
additional
methods
are
required
to
understand
long-term
impact
of
infections
on
immune
response.
Serological
testing,
well-documented
laboratory
practice,
measures
presence
antibodies
sample
uncover
information
about
host
immunity.
Although
proposed
applications
serological
clinical
use
have
previously
limited,
current
research
into
shown
growing
utility
these
settings.
To
name
few,
used
identify
patients
with
past
active
disease
monitor
vaccine
efficacy.
Test
result
interpretation,
however,
often
complicated
by
factors
that
include
poor
test
sensitivity
early
infection,
lack
response
some
individuals,
overlying
infection
vaccination
responses,
standardization
antibody
titers/levels
between
instruments,
unknown
titers
confer
protection,
large
between-individual
biological
variation
following
or
vaccination.
Thus,
three
major
components
this
review
will
examine
(1)
affect
utility:
performance,
matrices,
seroprevalence
concerns
viral
variants,
(2)
patient
response:
timing
sampling,
age,
sex,
body
mass
index,
immunosuppression
vaccination,
(3)
informative
testing:
identifying
surveillance
guide
health
practices,
examination
protective
should
be
beneficial
care
if
it
is
implemented
appropriately.
However,
as
other
developed
tests,
serology
modality
warrants
careful
consideration
limitations
evaluation
its
utility.Keywords:
SARS-CoV-2COVID-19serologyimmunityantibody
Disclosure
statementJT
receives
in-kind
support
from
Roche
Diagnostics.Additional
informationFundingThis
open-access
article
supported
funding
Canadian
Institutes
Health
Research
(Funding
Reference
Number
VR4-172753,
VS1-175526,
VS2-175572.
The Journal of Infectious Diseases,
Journal Year:
2023,
Volume and Issue:
230(1), P. e93 - e101
Published: Nov. 28, 2023
The
key
correlate
of
protection
respiratory
syncytial
virus
(RSV)
vaccines
and
monoclonal
antibodies
(mAb)
is
neutralization,
measured
using
sera
obtained
through
venipuncture.
Dried
blood
with
a
finger
prick
can
simplify
acquisition,
processing,
storage,
transport
in
trials,
thereby
reduce
costs.
In
this
study
we
validate
an
assay
to
measure
RSV
neutralization
dried
capillary
blood.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2022,
Volume and Issue:
unknown
Published: Dec. 16, 2022
The
antiviral
benefit
of
antibodies
can
be
compromised
by
viral
escape
especially
for
rapidly
evolving
viruses.
Therefore,
durable,
effective
must
both
broad
and
potent
to
counter
newly
emerging,
diverse
strains.
Discovery
such
is
critically
important
SARS-CoV-2
as
the
global
emergence
new
variants
concern
(VOC)
has
efficacy
therapeutic
vaccines.
We
describe
a
collection
neutralizing
monoclonal
(mAbs)
isolated
from
an
individual
who
experienced
breakthrough
infection
with
Delta
VOC.
Four
mAbs
potently
neutralize
Wuhan-Hu-1
vaccine
strain,
VOC,
also
retain
potency
against
Omicron
VOCs
through
BA.4/BA.5
in
pseudovirus-based
authentic
virus
assays.
Three
recently
circulating
XBB.1.5
BQ.1.1
one
neutralizes
SARS-CoV-1.
these
was
greater
than
all
but
that
had
been
approved
applications.
target
distinct
epitopes
on
spike
glycoprotein,
three
receptor
binding
domain
(RBD)
invariant
region
downstream
RBD
subdomain
1
(SD1).
pathways
we
defined
at
single
amino
acid
resolution
deep
mutational
scanning
show
they
conserved,
functionally
constrained
regions
suggesting
could
incur
fitness
cost.
Overall,
are
novel
their
breadth
across
VOCs,
epitope
specificity,
include
highly
mAb
targeting
rare
outside
SD1.
Vaccine,
Journal Year:
2024,
Volume and Issue:
42(22), P. 126029 - 126029
Published: June 4, 2024
The
level
of
neutralizing
antibodies
required
to
confer
protection
against
COVID-19
breakthrough
infections
(BIs)
is
unclear,
and
the
ability
know
immune
status
individuals
rapidly
changing
endemic
variants
limited.
We
assessed
longitudinal
serum
anti-RBD
antibody
levels
activities
(NTs)
Omicron
BA.5
XBB.1.5
in
healthcare
workers
following
fourth
monovalent
fifth
bivalent
BA.4-5
vaccines.
occurrence
BIs
was
also
followed,
pre-infection
were
compared
between
patients
who
developed
BI
those
did
not.
In
addition,
we
collected
whole
blood
samples
on
same
day
as
sera
stored
them
filter
papers
(nos.
545,
590,
424)
for
up
two
months,
then
measured
their
NTs
using
dried
spots
(DBS)
eluates,
with
paired
sera.
Pre-infection
lower
than
not,
but
not
different
them.
below
50
%
200-fold
diluted
might
be
one
indicators
high
risk
BI.
However,
at
6
months
after
dose
vaccine
this
threshold
almost
half
infection-naïve
participants.
DBS
eluates
strongly
correlated
sera,
time
temperature
stability
varied
type
paper;
no.
545
paper
found
most
suitable
NT
evaluation.